These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Predictive value of interim 18F-FDG-PET in patients with non-small cell lung cancer treated with definitive radiation therapy. Kim N; Kim JS; Geol Lee C PLoS One; 2020; 15(7):e0236350. PubMed ID: 32687531 [TBL] [Abstract][Full Text] [Related]
23. Incorporating radiomic feature of pretreatment 18F-FDG PET improves survival stratification in patients with EGFR-mutated lung adenocarcinoma. Chen YH; Wang TF; Chu SC; Lin CB; Wang LY; Lue KH; Liu SH; Chan SC PLoS One; 2020; 15(12):e0244502. PubMed ID: 33370365 [TBL] [Abstract][Full Text] [Related]
24. The predictive value of Mattoli MV; Massaccesi M; Castelluccia A; Scolozzi V; Mantini G; Calcagni ML Radiat Oncol; 2017 Jan; 12(1):4. PubMed ID: 28057034 [TBL] [Abstract][Full Text] [Related]
25. The role of Lee JW; Seo KH; Kim ES; Lee SM Eur Radiol; 2017 May; 27(5):1912-1921. PubMed ID: 27590191 [TBL] [Abstract][Full Text] [Related]
26. Prognostic Value of Computed Tomography and/or Moran A; Wang Y; Dyer BA; Yip SSF; Daly ME; Yamamoto T Clin Lung Cancer; 2021 Sep; 22(5):461-468. PubMed ID: 33931316 [TBL] [Abstract][Full Text] [Related]
27. Clinical application of Nakajo M; Jinguji M; Ito S; Tani A; Hirahara M; Yoshiura T Jpn J Radiol; 2024 Jan; 42(1):28-55. PubMed ID: 37526865 [TBL] [Abstract][Full Text] [Related]
28. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer. Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369 [TBL] [Abstract][Full Text] [Related]
29. F-18-FDG-avid lymph node metastasis along preferential lymphatic drainage pathways from the tumor-bearing lung lobe on F-18-FDG PET/CT in patients with non-small-cell lung cancer. Shigemoto Y; Suga K; Matsunaga N Ann Nucl Med; 2016 May; 30(4):287-97. PubMed ID: 27007128 [TBL] [Abstract][Full Text] [Related]
30. Prediction of local recurrence and distant metastasis using radiomics analysis of pretreatment nasopharyngeal [18F]FDG PET/CT images. Peng L; Hong X; Yuan Q; Lu L; Wang Q; Chen W Ann Nucl Med; 2021 Apr; 35(4):458-468. PubMed ID: 33543393 [TBL] [Abstract][Full Text] [Related]
31. [18F] FDG Positron Emission Tomography (PET) Tumor and Penumbra Imaging Features Predict Recurrence in Non-Small Cell Lung Cancer. Mattonen SA; Davidzon GA; Bakr S; Echegaray S; Leung ANC; Vasanawala M; Horng G; Napel S; Nair VS Tomography; 2019 Mar; 5(1):145-153. PubMed ID: 30854452 [TBL] [Abstract][Full Text] [Related]
32. Bone marrow segmentation and radiomics analysis of [ Milara E; Gómez-Grande A; Tomás-Soler S; Seiffert AP; Alonso R; Gómez EJ; Martínez-López J; Sánchez-González P Comput Methods Programs Biomed; 2022 Oct; 225():107083. PubMed ID: 36044803 [TBL] [Abstract][Full Text] [Related]
33. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system. Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008 [TBL] [Abstract][Full Text] [Related]
34. COV is a readily available quantitative indicator of metabolic heterogeneity for predicting survival of patients with early and locally advanced NSCLC manifesting as central lung cancer. Yu T Eur J Radiol; 2020 Nov; 132():109338. PubMed ID: 33068840 [TBL] [Abstract][Full Text] [Related]
35. Advances in Imaging and Automated Quantification of Malignant Pulmonary Diseases: A State-of-the-Art Review. Hochhegger B; Zanon M; Altmayer S; Pacini GS; Balbinot F; Francisco MZ; Dalla Costa R; Watte G; Santos MK; Barros MC; Penha D; Irion K; Marchiori E Lung; 2018 Dec; 196(6):633-642. PubMed ID: 30302536 [TBL] [Abstract][Full Text] [Related]
36. Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in penile cancer. Zhang S; Li W; Liang F Oncotarget; 2016 Jul; 7(30):48600-48606. PubMed ID: 27203206 [TBL] [Abstract][Full Text] [Related]
37. Lasnon C; Majdoub M; Lavigne B; Do P; Madelaine J; Visvikis D; Hatt M; Aide N Eur J Nucl Med Mol Imaging; 2016 Dec; 43(13):2324-2335. PubMed ID: 27325312 [TBL] [Abstract][Full Text] [Related]
38. Prognostic Significance of FDG Uptake of Bone Marrow on PET/CT in Patients With Non-Small-Cell Lung Cancer After Curative Surgical Resection. Lee JW; Na JO; Kang DY; Lee SY; Lee SM Clin Lung Cancer; 2017 Mar; 18(2):198-206. PubMed ID: 27495385 [TBL] [Abstract][Full Text] [Related]
39. Limited diagnostic value of Dual-Time-Point (18)F-FDG PET/CT imaging for classifying solitary pulmonary nodules in granuloma-endemic regions both at visual and quantitative analyses. Chen S; Li X; Chen M; Yin Y; Li N; Li Y Eur J Radiol; 2016 Oct; 85(10):1744-1749. PubMed ID: 27666611 [TBL] [Abstract][Full Text] [Related]
40. Impact of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Uptake on Preoperative Positron Emission Tomography/Computed Tomography in the Lymph Nodes of Patients with Primary Colorectal Cancer. Sasaki K; Kawasaki H; Sato M; Koyama K; Yoshimi F; Nagai H Dig Surg; 2017; 34(1):60-67. PubMed ID: 27454870 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]